局部晚期肺神经内分泌肿瘤手术切除结果
该研究回顾性分析因支气管类癌或大细胞神经内分泌癌(LCNEC)行解剖性肺切除且病理证实淋巴结阳性(pN+)的患者,比较不同组织学类型的生存差异。结果显示pN+支气管类癌(典型与非典型)5年生存率均为89%,而pN+ LCNEC为47%;LCNEC中pN+较pN0生存显著更差(47% vs 91%)。结论认为支气管类癌即使局部晚期仍以手术为主,LCNEC伴淋巴结转移预后差,需积极多学科治疗。
要点
- pN+支气管类癌(典型与非典型)5年生存率均为89%,手术仍是首选。
- pN+ LCNEC的5年生存率仅47%,显著低于pN0 LCNEC的91%。
- LCNEC伴淋巴结转移预后差,需积极多学科综合治疗。
核心结论
- 支气管类癌预后最佳,早期及局部晚期均以手术为主要治疗方式。
- LCNEC伴淋巴结转移预后差,需采用积极的多学科治疗策略。
研究设计与样本
- 回顾性分析因支气管类癌或LCNEC行解剖性肺切除且最终病理证实淋巴结阳性(pN+)的患者。
- 共325例肺神经内分泌肿瘤手术患者,其中89例有淋巴结受累。
主要发现
- pN+支气管类癌(典型与非典型)5年生存率均为89%。
- pN+ LCNEC的5年生存率为47%。
- 细胞类型在N0疾病中不影响预后,支气管类癌组N0与N+生存无差异。
- LCNEC组pN+的5年总生存率(47%)远差于pN0(91%)。
临床怎么用
- 支气管类癌伴淋巴结转移仍应积极手术切除。
- LCNEC伴淋巴结转移需多学科综合治疗,手术联合其他治疗模式。
局限性
- 回顾性单中心研究,样本量有限(89例pN+患者)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary neuroendocrine tumors include well-differentiated and poorly differentiated histology for which cell type has proved to be a determinant of survival in many studies. In patients diagnosed with bronchial carcinoid and large cell neuroendocrine carcinoma (LCNEC), surgery is the treatment of choice even in the case of locally advanced disease with lymph node involvement. METHODS: We retrospectively analyzed patients undergoing anatomic lung resection for bronchial carcinoid or LCNEC with lymph node involvement (N1/N2) at the final pathologic examination (pN+). Characteristics of patients and differences in overall survival and disease-free survival are presented according to tumor type. Overall survival of distinct histologic groups was compared with survival in our institutional experience in stage I patients, without nodal involvement (pN0). RESULTS: In all, 325 patients underwent surgical resection for neuroendocrine tumors; 89 patients had nodal involvement. Five-year survival was 89% in pN+ bronchial carcinoid both for typical carcinoid and atypical carcinoid but worse for pN+ LCNEC (47%). Cell type did not influence the prognosis in N0 disease, and no differences in survival were evident between N0 and N+ in the bronchial carcinoid group. In the group of LCNEC, 5-year overall survival was much worse for pN+ LCNEC (47%) compared with pN0 LCNEC (91%). CONCLUSIONS: Bronchial carcinoids have the best prognosis, and surgery remains the treatment of choice for both early and locally advanced disease. On the contrary, aggressive forms (LCNEC) with lymph nodal metastasis have a poor prognosis, and they need to be treated with an aggressive multidisciplinary approach.
引用
- Girelli L, Casiraghi M, Sandri A, et al. Results of Surgical Resection of Locally Advanced Pulmonary Neuroendocrine Tumors. Ann Thorac Surg. 2020. PMID: 33130114. doi:10.1016/j.athoracsur.2020.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。